Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Phase 2

Completed

Conditions: Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Interventions: Drug: Ibrutinib
Drug: Rituximab
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: vincristine
Drug: Prednisolone

First Posted Date: 2016-02-02

Last Posted Date: 2020-10-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 24

Registration Number: NCT02670616

Locations: 🇰🇷
Samsung Medical Center, Seoul, Seoul, Gangnam-gu, Korea, Republic of

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Not Applicable

Completed

Conditions: Docetaxel Chemotherapy
Breast Cancer

Interventions: Drug: EVONAIL® solution

First Posted Date: 2016-02-02

Last Posted Date: 2017-04-28

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 100

Registration Number: NCT02670603

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

Conditions: Stroke

First Posted Date: 2016-01-29

Last Posted Date: 2017-04-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 120

Registration Number: NCT02668627

Locations: 🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes

Not Applicable

Conditions: Chronic Renal Failure

Interventions: Drug: Methylprednisolone

First Posted Date: 2016-01-27

Last Posted Date: 2016-04-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 154

Registration Number: NCT02664493

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy

Completed

Conditions: Gynecologic Neoplasms
Abdominal Neoplasms

Interventions: Other: Augmented ventilation
Other: Fluid loading

First Posted Date: 2016-01-12

Last Posted Date: 2016-03-04

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 38

Registration Number: NCT02653469

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer

Conditions: Metastatic Cancer

Interventions: Other: molecular profiling, patient derived cells

First Posted Date: 2016-01-05

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 500

Registration Number: NCT02646228

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Korea, Republic of

Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Not Applicable

Recruiting

Conditions: Pediatric Cancer Patients

Interventions: Radiation: Proton therapy

First Posted Date: 2016-01-01

Last Posted Date: 2016-10-14

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 400

Registration Number: NCT02644993

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Phase 2

Conditions: Relapsed Pediatric Solid Tumor
Refractory Pediatric Solid Tumor
Relapsed Pediatric AML
Refractory Pediatric AML

Interventions: Procedure: CancerSCAN™
Drug: Ifosfamide
Drug: Carboplatin
Drug: Etoposide
Drug: Fludarabine
Drug: Cytarabine
Drug: Pazopanib
Drug: Sorafenib
Drug: Axitinib
Drug: Crizotinib
Drug: Dasatinib
Drug: Erlotinib
Drug: Everolimus
Drug: Imatinib
Drug: Ruxolitinib
Drug: Vandetanib
Drug: Vemurafenib
Drug: Trastuzumab

First Posted Date: 2015-12-23

Last Posted Date: 2020-03-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 90

Registration Number: NCT02638428

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome

Conditions: Irritable Bowel Syndrome

First Posted Date: 2015-12-23

Last Posted Date: 2015-12-24

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 118

Registration Number: NCT02638870

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial

Phase 2

Conditions: Liver Neoplasm
Proton Therapy

Interventions: Radiation: Proton arm

First Posted Date: 2015-12-17

Last Posted Date: 2018-04-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 66

Registration Number: NCT02632864

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy